Plain-English translation of NCT07031817 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new diagnostic tool that combines a blood test with a mood questionnaire to help doctors accurately identify bipolar disorder in patients who come to primary care with depression. Currently, many people with bipolar disorder are mistakenly diagnosed with regular depression because the two conditions look very similar, especially when patients are in a depressive phase. This research aims to develop a faster, more reliable way to catch bipolar disorder early so patients get the right treatment from the start.
Bipolar disorder is often misdiagnosed as regular depression in primary care, leading patients to receive medications that can actually make bipolar disorder worse. This trial exists to create a simple blood test that could help primary care doctors accurately identify bipolar disorder when patients first seek help, so they can receive appropriate treatment immediately.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a blood sample drawn for analysis by the investigational blood test and complete mood questionnaires that doctors use to assess mood disorders. You will also share some basic information about your medical and psychiatric history. This is a diagnostic study only, so there is no medication or treatment involved—the goal is simply to evaluate how well the blood test works compared to standard psychiatric screening tools.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
France